More than 500,000 premature babies were born in the U.S. in 2010 and approximately 15 million babies were born premature worldwide. Many of these babies require medical care in the Neonatal Intensive Care Unit (NICU). It is estimated that 45% to 65% of medications are used off-label in the NICU setting, and neonates are at higher risk for preventable adverse drug events and medication errors. Additionally, providing parenteral nutrition in this population is important for improving growth outcomes; however, parenteral nutrition is a ‘high-alert’ medication, associated with an increased risk for harm if managed inappropriately. Consequently, drug dosing and parenteral nutrition support are particularly challenging and complex in the neonatal population.
|NeoFax is designed to help clinicians improve outcomes and efficiencies with tools to:|
||Safely and efficiently prescribe, calculate, order, formulate, and administer drug therapy and parenteral nutrition for infants|
||Provide age and indication-specific drug dosing calculators, derived from evidence-based neonatal drug information for more than 180 substances decreasing the time spent creating drug orders|
||Efficiently and safely manage complex scenarios for neonatal patients|
||Make accurate and informed treatment decisions, while minimizing errors|
NeoFax is also easy to use and its intuitive interface makes this a must-have resource for physicians, nurses, nutritionists, and pharmacists. Using NeoFax will help improve consistency across the neonatal care team and reduce medication errors.